alpha,beta-methyleneadenosine 5'-triphosphate has been researched along with Chronic Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faltynek, CR; Honore, P; Jarvis, MF; Johnston, JF; Kage, K; Lynch, K; Mikusa, J; Watt, AT; Wyatt, JR | 1 |
| Chu, KL; Faltynek, CR; Honore, P; Jarvis, MF; Lee, CH; McGaraughty, S; Mikusa, J; Wismer, CT; Zhu, CZ | 1 |
2 other study(ies) available for alpha,beta-methyleneadenosine 5'-triphosphate and Chronic Disease
| Article | Year |
|---|---|
Analgesic profile of intrathecal P2X(3) antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats.
Topics: Acute Disease; Adenosine Triphosphate; Animals; Antineoplastic Agents; Chronic Disease; Hyperalgesia; Injections, Spinal; Ligation; Male; Neuralgia; Neurogenic Inflammation; Nociceptors; Oligonucleotides, Antisense; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X3; Spinal Nerves | 2002 |
Effects of A-317491, a novel and selective P2X3/P2X2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration.
Topics: Acute Disease; Adenosine Triphosphate; Analgesics, Non-Narcotic; Animals; Carrageenan; Chronic Disease; Hindlimb; Hot Temperature; Inflammation; Injections, Spinal; Male; Motor Activity; Neuropeptides; Pain; Pain Measurement; Peripheral Nervous System Diseases; Phenols; Polycyclic Compounds; Purinergic P2 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X2; Receptors, Purinergic P2X3 | 2003 |